Although recent clinical observations suggest that features such as intratumoural steatosis17, reduced B cell infiltration3 and downregulation of the chemokine CXCL13 (ref. 17) may influence immune responsiveness in MASH-HCC, the mechanisms linking tumour metabolism to immune regulation remain poorly defined. Here, CXCL13 is linked to neoplasm.